Page 221 - Read Online
P. 221

Page 14 of 15                                                 Cheng et al. Vessel Plus 22020;4:17  I  http://dx.doi.org/10.20517/2574-1209.2020.08

                   Supplement/I10-2.005 [Last accessed on 6 May 2020]
               91.  Antwi-Baffour S, Malibha-Pinchbeck M, Stratton D, Jorfi S, Lange S, et al. Plasma mEV levels in Ghanain malaria patients with low
                   parasitaemia are higher than those of healthy controls, raising the potential for parasite markers in mEVs as diagnostic targets. J Extracell
                   Vesicles 2020;9:1697124.
               92.  Hede MS, Fjelstrup S, Lötsch F, Zoleko RM, Klicpera A, et al. Detection of the malaria causing plasmodium parasite in saliva from
                   infected patients using topoisomerase I activity as a biomarker. Sci Rep 2018;8:4122.
               93.  Krampa FD, Aniweh Y, Awandare GA, Kanyong P. Recent progress in the development of diagnostic tests for malaria. Diagnostics (Basel)
                   2017;7:54.
               94.  Choi DS, Kim DK, Kim YK, Gho YS. Proteomics, transcriptomics and lipidomics of exosomes and ectosomes. Proteomics 2013;13:1554-71.
               95.  Abdi A, Yu L, Goulding D, Rono MK, Bejon P, et al. Proteomic analysis of extracellular vesicles from a Plasmodium falciparum Kenyan
                   clinical isolate defines a core parasite secretome. [version 2; peer review: 2 approved, 1 approved with reservations]. Wellcome Open Res
                   2017;2:50.
               96.  Tiberti N, Latham SL, Bush S, Cohen A, Opoka RO, et al. Exploring experimental cerebral malaria pathogenesis through the
                   characterisation of host-derived plasma microparticle protein content. Sci Rep 2016;6:37871.
               97.  Antwi-Baffour S, Adjei JK, Agyemang-Yeboah F, Annani-Akollor M, Kyeremeh R, et al. Proteomic analysis of microparticles isolated
                   from malaria positive blood samples. Proteome Sci 2016;15:5.
               98.  Gualdrón-López M, Flannery EL, Kangwanrangsan N, Chuenchob V, Fernandez-Orth D, et al. Characterization of plasmodium vivax
                   proteins in plasma-derived exosomes from malaria-infected liver-chimeric humanized Mice. Front Microbiol 2018;9:1271.
               99.  Hanna J, Hossain GS, Kocerha J. The Potential for microRNA therapeutics and clinical research. Front Genet 2019;10:478.
               100. Saliminejad K, Khorram Khorshid HR, Soleymani Fard S, Ghaffari SH. An overview of microRNAs: biology, functions, therapeutics,
                   and analysis methods. J Cell Physiol 2019;234:5451-65.
               101. Chen SY, Wang Y, Telen MJ, Chi JT. The genomic analysis of erythrocyte microRNA expression in sickle cell diseases. PLoS One
                   2008;3:e2360.
               102. Chen X, Ba Y, Ma L, Cai X, Yin Y, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer
                   and other diseases. Cell Res 2008;18:997-1006.
               103. Hammond SM. An overview of microRNAs. Adv Drug Deliv Rev 2015;87:3-14.
               104. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, et al. Circulating microRNAs as stable blood-based markers for cancer
                   detection. Proc Natl Acad Sci U S A 2008;105:10513-8.
               105. Reid G, Kirschner MB, van Zandwijk N. Circulating microRNAs: association with disease and potential use as biomarkers. Crit Rev
                   Oncol Hematol 2011;80:193-208.
               106. Wang W, Li R, Meng M, Wei C, Xie Y, et al. MicroRNA profiling of CD3+ CD56+ cytokine-induced killer cells. Sci Rep 2015;5:9571.
               107. Babatunde KA, Mbagwu S, Hernández-Castañeda MA, Adapa SR, Walch M, et al. Malaria infected red blood cells release small
                   regulatory RNAs through extracellular vesicles. Sci Rep 2018;8:884.
               108. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004;116:281-97.
               109. Wang J, Sen S. MicroRNA functional network in pancreatic cancer: from biology to biomarkers of disease. J Biosci 2011;36:481-91.
               110.  Chen X, Jin Y, Feng Y. Evaluation of plasma extracellular vesicle microRNA signatures for lung adenocarcinoma and granuloma with
                   monte-carlo feature selection method. Front Genet 2019;10:367.
               111.  Sartori MT, Della Puppa A, Ballin A, Saggiorato G, Bernardi D, et al. Prothrombotic state in glioblastoma multiforme: an evaluation of
                   the procoagulant activity of circulating microparticles. J Neurooncol 2011;104:225-31.
               112.  Zwicker JI, Liebman HA, Neuberg D, Lacroix R, Bauer KA, et al. Tumor-derived tissue factor-bearing microparticles are associated with
                   venous thromboembolic events in malignancy. Clin Cancer Res 2009;15:6830-40.
               113.  da Silva EFR, Fonseca FAH, França CN, Ferreira PRA, Izar MCO, et al. Imbalance between endothelial progenitors cells and
                   microparticles in HIV-infected patients naive for antiretroviral therapy. AIDS 2011;25:1595-601.
               114.  Pelletier F, Garnache-Ottou F, Angelot F, Biichlé S, Vidal C, et al. Increased levels of circulating endothelial-derived microparticles and
                   small-size platelet-derived microparticles in psoriasis. J Invest Dermatol 2011;131:1573-6.
               115.  Stępień E, Stankiewicz E, Zalewski J, Godlewski J, Zmudka K, et al. Number of microparticles generated during acute myocardial
                   infarction and stable angina correlates with platelet activation. Arch Med Res 2012;43:31-5.
               116.  Xue S, Cai X, Li W, Zhang Z, Dong W, et al. Elevated plasma endothelial microparticles in Alzheimer’s disease. Dement Geriatr Cogn
                   Disord 2012;34:174-80.
               117.  Bondar G, Xu W, Elashoff D, Li X, Faure-Kumar E, et al. Comparing NGS and NanoString platforms in peripheral blood mononuclear
                   cell transcriptome profiling for advanced heart failure biomarker development. J Biol Methods 2020;7:e123.
               118.  Manzano-Román R, Siles-Lucas M. MicroRNAs in parasitic diseases: potential for diagnosis and targeting. Mol Biochem Parasitol
                   2012;186:81-6.
               119.  Eichenberger RM, Talukder MH, Field MA, Wangchuk P, Giacomin P, et al. Characterization of Trichuris muris secreted proteins and
                   extracellular vesicles provides new insights into host-parasite communication. J Extracell Vesicles 2018;7:1428004.
               120. Eichenberger RM, Ryan S, Jones L, Buitrago G, Polster R, et al. Hookworm secreted extracellular vesicles interact with host cells and
                   prevent inducible colitis in mice. Front Immunol 2018;9:850.
               121. Xue X, Zhang Q, Huang Y, Feng L, Pan W. No miRNA were found in Plasmodium and the ones identified in erythrocytes could not be
                   correlated with infection. Malar J 2008;7:47.
               122. Chamnanchanunt S, Kuroki C, Desakorn V, Enomoto M, Thanachartwet V, et al. Downregulation of plasma miR-451 and miR-16 in
   216   217   218   219   220   221   222   223   224   225   226